prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype Basal, Revised. F. Pathologic Interpretation: A. Left breast mastectomy (fresh) 1 - stitch superior /2 - stitch lateral: Infiltrating ductal adenocarcinoma, high nuclear grade (5.0 cm in greatest dimension). Margins free of tumor. Florid adenosis and stroma fibrosis. ER, PR and HER 2-new were ordered, addendum to follow. B. Sentinel node #1-fs. Lymph node, no malignancy seen. Keratin ordered, addendum to follow. C. Sentinel node #2-fs. Lymph node, no malignancy seen. Keratin ordered, addendum to follow. D. Sentinel node #3- fs. Lymph node, no malignancy seen. Keratin ordered, addendum to follow. E. Left breast implant capsule short stich superior, long stich lateral: Implant capsule. F. Left breast implant: See gross description. Surgical Pathology Cancer Summary. Macroscopic: Mastectomy. Lymph node: Sentinel lymph node. Specimen Size: Greatest dimension:19.0 cm/additional dimensions 18.5 x 2.3 cm. Laterality: Left. Tumor Site: Not specified. Microscopic: Size of invasive component: Greatest dimension 5.0 cm/ additional dimensions: 2.0x3.0cm. Histologic Type: Invasive ductal carcinoma. Tubule Formation: Minimal less than 10% (score=3). Nuclear Pleomorphism: marked variation in size, nucleoli, chromatin clumping, etc (score=3). For a 40 x objective with a field area of 0.152 mm2: score 1. Total Nottingham Score: Grade II: 6-7 points. Lymph nodes (pN): Pending keratins. Primary tumor: (pT3c) tumor more than 5.0 cm in greatest dimension. Distant Metastasis (pMX): Cannot be assessed. Margins uninvolved by invasive carcinoma/distance from closest margin: 0.1 cm deep. Venous Lymphatic: Absent. Microcalcifications: Not identified. NOTE: Some immunohistochemical antibodies are analyte specific resgents (ASRs) validated by our laboratory (Her 2, Parvo, H. pylori, HBcore). These ASRs are clinically usefd indicators that do. not require FDA approval. These clones are A# stains are used. with formalin or molecular fixed, paramfn embedded tissue. Detection is by LSAB. The results are read by a pathologiat as positive or negative. MD. SURGICAL PATHOL Report. As the attending pathologist, / attest that 1: (i) Examined the relevant. preperation(s) for the specimen(s); and (#) Rendered the diagnosis(es). Amendments. Amended: MD. Reason: Diagnosis editing/clarification. Previous Signout Date: Procedures/Addenda. Addendum. Date Complete: Addendum Diagnosis. A. Left breast mastectomy (fresh) 1 - stitch superior / 2 - stitch lateral: Tumor is negative for ER, PR and HER 2. HLA-DR ordered addendum. B. Sentinel node #1-fs (. Keratin is negative for tumor. C. Sentinel node #2-fs I. Keratin is negative for tumor. D. Sentinel node #3- fs I. Keratin is negative for tumor. MD. Addendum. Date Complete: Addendum Diagnosis. A. Tumor is positive for HLA-DR, which along with morphology supports a medullary subtype. , MD. Intraoperative Consultation. AFS. Left breast mastectomy (fresh) 1 - stitch superior /2 - stitch lateral: BFS. Sentinel node #1-1 fs. One lymph node, no tumor seen. CFS. Sentinel node #2- fs. One lymph node, no tumor seen. DFS. Sentinel node #3- fs (. One lymph node, no tumor seen. SURGICAL PATHOL Report. MD. Clinical History: Patient is a. with breast cancer. Pre Operative Diagnosis: Breast cancer. Specimen(s) Received: A: Left breast mastectomy (fresh) 1 - stitch superior / 2 - stitch lateral. B: Sentinel node #1-fs. C: Sentinel node #2- fs. D: sentinel node #3- fs (. E: Left breast implant capsule shrot stich sueperior, long stich lateral. F: Left breast implant. Gross Description: A. Received fresh and labeled "left breast mastectomy (fresh) 1-stitch superior / 2 - stitch lateral consists skin mastectomy. weighs 380.0 grams and measure 19.0 x 18.5 x 2.3 cm. The areola complex measure 3.7 x 2.4 cm and it is grossly. unremarkable with no areas indurations. Sectioning of the specimen a tumor located in the upper outer quadrant measure. 5.0 cm from superior to inferior, 2.0 cm from superficial to deep and 3.0 cm from medial to lateral. Tumor located 0.1 cm. away from the deep margin. The tumor is well encapsulated and has lobulated appearance. The second III-define area of. fibrosis is present at the upper inner upper quadrant, 2.5 cm x 1.0 x 1.0 cm. The overall stoma to fat to ratio(is. approximately 25.0% stroma. No other suspicious areas identified after serial sectioning. Sections submitted as follows. 1. Sections of nipple. 2-4. Sections of the lesion in relation to the deep margin. 5. Sections of the lesion in relation to adjection fibrotic stroma. 6&7. Sections from the upper inner quadrant stroma with sixteen ill-defined areas described. 8&9. Sections from the lower inner quadrant stroma. 10&11. Sections from the upper outer quadrant stroma. 12&13. Sections from the lower outer quadrant stroma. B. Received fresh and labeled "sentinel node #1- fs. consists of a lymph node, 2.0 x 1.5 x 1.0 cm. Specimer bisected. and submitted in toto in one cassette for frozen. C. Received fresh and labeled "sentinel node #2- fs 1. consists of a lymph node, 2.0 x 1.5 x 1.0 cm. Specimen. bisected and submitted in toto in one cassette for frozen. D. Received fresh and labeled "sentinel node #3- fs (. consists of a lymph node, 1.5 x 1.2 x 1.0 cm. Specimen. bisected and submitted in toto in one cassette for frozen. E. Received in formalin and labeled "left breast implant capsule short stich sueperior, long stich lateral" consists of two. pieces irregular shaped membrane tissue, 7.0 x 6.0 x 3.0 cm in aggregate. Representative sections submitted in two. cassettes. F. Received in formalin and labeled "left breast implant" consists of a breast prosthesis which weighs 1.97.0 grams and. measure 10.0 cm in diameter by 3.5 cm. The following inscription is attached. Gross description. only. ICD-9(s): 174.8. Addendum. F. Client: Specimen(s) Received: A: Left breast mastectomy (fresh) 1 - stitch superior / 2 - stitch lateral. B: Sentinel node #1- fs. C: Sentinel node #2- fs ,. D: sentinel node #3- fs. E: Left breast implant capsule shrot stich sueperior, long stich lateral. F: Left breast implant. Date Ordered: 1. Addendum Diagnosis. A. Left breast mastectomy (fresh) 1 - stitch superior /2 - stitch lateral: Tumor is negative for ER, PR and HER 2. HLA-DR ordered addendum. B. Sentinel node #1- fs. Keratin is negative for tumor. C. Sentinel node #2- fs (. Keratin is negative for tumor. D. Sentinel node #3- fs. Keratin is negative for tumor. , MD. 1. Addendum. Client: Specimen(s) Received: A: Left breast mastectomv (fresh) 1 - stitch superior 2 - stitch lateral. B: Sentinel node #1- fs. C: Sentinel node #2- fs. D: sentinel node #3-fs. E: Left breast implant capsule shrot stich sueperior, long stich lateral. F: Left breast implant. Addendum Diagnosis. A. Tumor is positive for HLA-DR, which along with morphology supports a medullary subtype. , MD.

expanded version (tokens=2285) : 
 Histological classification: Infiltrating ductal adenocarcinoma, high nuclear grade in the left breast mastectomy specimen. The subtype is Basal, revised. Additionally, it is a medullary subtype based on morphology and HLA-DR positivity.

Nuclear grade: marked variation in size, nucleoli, chromatin clumping, etc (score=3).

Histological grade: Grade II: 6-7 points for a 40x objective with a field area of 0.152 mm2.

Lymphovascular invasion: Absent.

Receptor status: ER, PR, and HER 2-new ordered with addendum to follow. The initial addendum shows that the tumor is negative for ER, PR, and HER 2. HLA-DR is positive.

Ancillary testing: Keratin ordered for all three sentinel lymph nodes, and the results are negative for tumor cells. 

Other findings: Florid adenosis and stroma fibrosis are present. There is no mention of necrosis or calcification. Some immunohistochemical antibodies used are analyte specific resgents (ASRs) validated by the laboratory (Her 2, Parvo, H. pylori, HBcore). 

In summary, the left breast mastectomy specimen shows an infiltrating ductal adenocarcinoma, high nuclear and histological grades, absent lymphovascular invasion, and basal subtype revised, with additional features suggestive of a medullary subtype

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=2441) : 
 Left breast mastectomy specimen shows infiltrating ductal adenocarcinoma, high histological and nuclear grades, with no lymphovascular invasion. Basal subtype revised, while HLA-DR is positive, suggesting a medullary subtype. ER, PR & HER2 status were ordered with addendum to follow. The initial addendum is negative for all three receptors. Sentinel lymph nodes are negative for tumor cells by keratin staining. Positive HLA-DR staining may indicate a better prognosis and response to treatment in this case.

